AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...

Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...

Dr. Taylor Theunissen performs autologous breast reconstruction procedures in Baton Rouge, offering cancer survivors natural tissue-based options for post-mastectomy reconstruction with improved ...

Heart disease and breast cancer are two of the most significant health threats facing Black women today. Here's ...

Oklahoma Cancer Specialists and Research Institute has announced its new status as a main member of NRG Oncology, enhancing ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.